4D pharma

Manchester, United Kingdom Founded: 2008 • Age: 18 yrs
Drugs from gut bacteria are developed for multiple diseases.
Request Access

About 4D pharma

4D pharma is a company based in Manchester (United Kingdom) founded in 2008.. The company has 106 employees as of December 31, 2021. 4D pharma has completed 2 acquisitions, including BIOMAR and GT Biologics. 4D pharma operates in a competitive market with competitors including Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.

  • Headquarter Manchester, United Kingdom
  • Employees 106 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name 4D Pharma Plc
  • Date of Incorporation 10 Jan, 2014
  • Jurisdiction LEEDS
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $685.4 K (USD)
    153
    as on Dec 31, 2020
  • Net Profit
    $-33.32 M (USD)
    -8
    as on Dec 31, 2020
  • EBITDA
  • Latest Funding Round
    $24 M (USD), Post-IPO

    Mar 17, 2021

  • Investors
  • Employee Count
    106

    as on Dec 31, 2021

  • Investments & Acquisitions
    BIOMAR

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of 4D pharma

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $24.0M
  • First Round

    (01 Feb 2014)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2021 Amount Post-IPO - 4D pharma Valuation

investors

Jul, 2020 Amount Post-IPO - 4D pharma Valuation

investors

Feb, 2020 Amount Post-IPO - 4D pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by 4D pharma

4D pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BIOMAR and GT Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Developing naturally occurring human bacteria as biotherapeutics for gastrointestinal diseases.
2007
Natural products from marine microorganisms are discovered and developed.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - 4D pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

4D Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 4D pharma

4D pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for neurodegenerative and immunology disorders are developed.
domain founded_year HQ Location
Therapies for immunological and neurological disorders are developed.
domain founded_year HQ Location
Plasma-derived therapies are developed to treat multiple diseases.
domain founded_year HQ Location
Small molecule protein degraders are developed for various disorders.
domain founded_year HQ Location
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
domain founded_year HQ Location
Biosolutions and enzymes are developed for biotechnology applications across industries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 4D Pharma

Frequently Asked Questions about 4D pharma

When was 4D pharma founded?

4D pharma was founded in 2008 and raised its 1st funding round 6 years after it was founded.

Where is 4D pharma located?

4D pharma is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.

How many employees does 4D pharma have?

As of Dec 31, 2021, the latest employee count at 4D pharma is 106.

What is the annual revenue of 4D pharma?

Annual revenue of 4D pharma is $685.4K as on Dec 31, 2020.

What does 4D pharma do?

Founded in 2008 and based in Manchester, United Kingdom, the company operates in the biotechnology sector. Live biotherapeutic products are developed using the MicroRx platform, derived from gut bacteria. These products target diseases such as cancer, gastrointestinal disorders, respiratory conditions, and central nervous system ailments. Operations focus on research and development for therapeutic applications across these areas.

Who are the top competitors of 4D pharma?

4D pharma's top competitors include Novozymes, BioNTech and Generate Biomedicines.

How many acquisitions has 4D pharma made?

4D pharma has made 2 acquisitions, including BIOMAR, and GT Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available